Omega-3 fatty acids, polymorphisms and lipid related cardiovascular disease risk factors in the Inuit population

Nutrition and Metabolism

Volumn 10, Issue 1, 2013, Pages

  Rudkowska, Iwona ^a,b   Ouellette, Catherine ^a   Dewailly, Eric ^b   Hegele, Robert A ^c   Boiteau, Véronique ^b   Dubé Linteau, Ariane ^b   Abdous, Belkacem ^b   Proust, Françoise ^b   Giguère, Yves ^b   Julien, Pierre ^b   Château Degat, Marie Ludivine ^b   Vohl, Marie Claude ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Gene nutrient interactions; n 3 PUFAs; Nutrigenetics; Plasma lipids

Indexed keywords

APOLIPOPROTEIN A4; APOLIPOPROTEIN A5; APOLIPOPROTEIN C3; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; ERYTHROCYTE COUNT; ESKIMO; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOTE; TRIACYLGLYCEROL BLOOD LEVEL;

CROHN DISEASE; CYTOKINES; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; HUMANS; LIPIDS; RECURRENCE; REMISSION INDUCTION;

EID: 84874771636     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-10-26     Document Type: Article

References (31)

1. Low incidence of cardiovascular disease among the Inuit-what is the evidence? Bjerregaard P, Young TK, Hegele RA, Atherosclerosis 2003 166 351 357 10.1016/S0021-9150(02)00364-7 12535749
2. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Lancet 2007 370 1829 1839 18061058
3. Contribution of Selected Traditional and Market Foods to the Diet of Nunavik Inuit Women. Blanchet C, Dewailly E, Ayotte P, Bruneau S, Receveur O, Holub BJ, Can J Diet Pract Res 2000 61 50 59 11551348
4. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. Mozaffarian D, Wu JH, J Am Coll Cardiol 2011 58 2047 2067 10.1016/j.jacc.2011.06.063 22051327
5. Is marine mammal fat or fish intake most strongly associated with omega-3 blood levels among the Nunavik Inuit? Lucas M, Proust F, Blanchet C, Ferland A, Dery S, Abdous B, Prostaglandins Leukot Essent Fatty Acids 2010 83 143 150 10.1016/j.plefa.2010.06.006 20634051
6. Cardiovascular burden and related risk factors among Nunavik (Quebec) Inuit: insights from baseline findings in the circumpolar Inuit health in transition cohort study. Chateau-Degat ML, Dewailly E, Louchini R, Counil E, Noel M, Ferland A, Can J Cardiol 2010 26 190 196 10.1016/S0828-282X(10)70398-6 20548980
7. Gene-diet interactions on plasma lipid levels in the Inuit population. Rudkowska I, Dewailly E, Hegele RA, Boiteau V, Dube-Linteau A, Abdous B, Br J Nutr 2013 109 953 961 10.1017/S0007114512002231 23021345
8. Are Canadian Inuit at increased genetic risk for coronary heart disease? Hegele RA, Young TK, Connelly PW, J Mol Med 1997 75 364 370 10.1007/ s001090050122 9181478
9. Nunavik Inuit Health Survey 2004, Qanuippitaa? How are we? Dewailly E, Chateau-Degat ML, Ekoe JM, Ladouceur R, Rochette L, Québec: Institut national de santé publique du Québec (INSPQ) & Nunavik Regional Board of Health and Social Services (NRBHSS). Status of Cardiovascular Disease and Diabetes in Nunavik 2007 23626753
10. Criteria for definition of overweight in transition: background and recommendations for the United States. Kuczmarski RJ, Flegal KM, Am J Clin Nutr 2000 72 1074 1081 11063431
11. Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. McNamara JR, Schaefer EJ, Clin Chim Acta 1987 166 1 8 10.1016/0009-8981(87)90188-4 3608193
12. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Friedewald WT, Levy RI, Fredrickson DS, Clin Chem 1972 18 499 502 4337382
13. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Laurell CB, Anal Biochem 1966 15 45 52 10.1016/0003-2697(66)90246-6 5959431
14. Blanchet C, Rochette L, Nutrition and Food Consumption among the Inuit of Nunavik Quebec, Canada: Institut national de santé publique du Québec & Régie régionale de la santé et des services sociaux du Nunavik. Ref Type: Generic 2008
15. Dairy product intake and its association with body weight and cardiovascular disease risk factors in a population in dietary transition. Ferland A, Lamarche B, Chateau-Degat ML, Counil E, Anassour-Laouan-Sidi E, Abdous B, J Am Coll Nutr 2011 30 92 99 21730217
16. Time course of changes in porcine myocardial phospholipid levels during ischemia. A reassessment of the lysolipid hypothesis. Shaikh NA, Downar E, Circ Res 1981 49 316 325 10.1161/01.RES.49.2.316 7249269
17. Direct transesterification of all classes of lipids in a one-step reaction. Lepage G, Roy CC, J Lipid Res 1986 27 114 120 3958609
18. Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J, Atherosclerosis 2006 189 19 30 10.1016/j.atherosclerosis.2006.02.012 16530201
19. CETP gene variation: relation to lipid parameters and cardiovascular risk. Boekholdt SM, Kuivenhoven JA, Hovingh GK, Jukema JW, Kastelein JJ, van TA, Curr Opin Lipidol 2004 15 393 398 10.1097/01.mol.0000137226.54278.60 15243211
20. Gene-environment interactions of CETP gene variation in a high cardiovascular risk Mediterranean population. Corella D, Carrasco P, Fito M, Martinez-Gonzalez MA, Salas-Salvado J, Aros F, J Lipid Res 2010 51 2798 2807 10.1194/jlr.P005199 20581105
21. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. Thompson A, Di AE, Sarwar N, Erqou S, Saleheen D, Dullaart RP, JAMA 2008 299 2777 2788 10.1001/jama.299.23. 2777 18560005
22. Cholesteryl ester transfer protein I405V polymorphism influences apolipoprotein A-I response to a change in dietary fatty acid composition. Darabi M, Abolfathi AA, Noori M, Kazemi A, Ostadrahimi A, Rahimipour A, Horm Metab Res 2009 41 554 558 10.1055/s-0029-1192034 19242900
23. The M235T polymorphism in the AGT gene and CHD risk: evidence of a Hardy-Weinberg equilibrium violation and publication bias in a meta-analysis. Zafarmand MH, van der Schouw YT, Grobbee DE, de Leeuw PW, Bots ML, PLoS One 2008 3 2533 10.1371/journal.pone.0002533 18575631
24. Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men. Delgado-Lista J, Perez-Jimenez F, Ruano J, Perez-Martinez P, Fuentes F, Criado-Garcia J, J Lipid Res 2010 51 63 73 10.1194/jlr.M800527-JLR200 19592705
25. Apolipoprotein A5 Polymorphisms Interact with Total Dietary Fat Intake in Association with Markers of Metabolic Syndrome in Puerto Rican Older Adults. Mattei J, Demissie S, Tucker KL, Ordovas JM, J Nutr 2009 139 2301 2308 10.3945/jn.109.109900 19828688
26. APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population. Sanchez-Moreno C, Ordovas JM, Smith CE, Baraza JC, Lee YC, Garaulet M, J Nutr 2011 141 380 385 10.3945/jn.110.130344 21209257
27. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study. Lai CQ, Corella D, Demissie S, Cupples LA, Adiconis X, Zhu Y, Circulation 2006 113 2062 2070 10.1161/CIRCULATIONAHA.105.577296 16636175
28. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Talmud PJ, Hawe E, Martin S, Olivier M, Miller GJ, Rubin EM, Hum Mol Genet 2002 11 3039 3046 10.1093/hmg/11.24.3039 12417525
29. Pharmacogenetic association of the APOA1/C3/A4/A5 gene cluster and lipid responses to fenofibrate: the genetics of lipid-lowering drugs and diet network study. Liu Y, Ordovas JM, Gao G, Province M, Straka RJ, Tsai MY, Pharmacogenet Genomics 2009 19 161 169 10.1097/FPC.0b013e32831e030e 19057464
30. Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Russo GT, Meigs JB, Cupples LA, Demissie S, Otvos JD, Wilson PW, Atherosclerosis 2001 158 173 181 10.1016/S0021-9150(01)00409-9 11500189
31. The SstI polymorphic site at the apolipoprotein C-III gene predicts plasma low-density lipoprotein response to changes in dietary fat in young men. Lopez-Miranda J, Ordovas JM, Marin C, Circulation 1994 90